Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marine Quint"'
Autor:
Delphine Lebon, Adèle Dujardin, Alexis Caulier, Magalie Joris, Amandine Charbonnier, Bérengère Gruson, Marine Quint, Sandrine Castelain, Catherine François, Marie-Noëlle Lacassagne, Nicolas Guillaume, Jean-Pierre Marolleau, Pierre Morel
Publikováno v:
Leukemia Research. 125:107005
Steroid-refractory graft-versus-host disease (SR-GVHD) is a challenging complication of allogeneic hematopoietic stem cell transplantation, and leads to high morbidity and mortality rates. The orally administered, selective Janus-associated kinase 1/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d33cec9b4d72a147fe3f177a554ff310
https://doi.org/10.1016/j.leukres.2022.107005
https://doi.org/10.1016/j.leukres.2022.107005
Autor:
Judith Desoutter, Véronique Harrivel, Alice Marceau, Delphine Lebon, Alexis Caulier, Jean-Pierre Marolleau, Marine Quint, Nicolas Duployez, Amandine Charbonnier, Lavinia Merlusca, Magalie Joris, Thomas Boyer, Lydia Montes, Marie-Noëlle Lacassagne, Audrey Da Rocha, Mathieu Sage, Nicolas Guillaume
Publikováno v:
Blood. 138:2928-2928
INTRODUCTION : HSCT remains the best curative treatment in eligible AML patients with adverse or intermediate cytogenetics according to the ELN classification, and for those with unfavorable molecular markers at diagnostic or with a positive measurab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d80de1373a088e90dcc68c5fb54c36f3
https://doi.org/10.1182/blood-2021-145523
https://doi.org/10.1182/blood-2021-145523
Autor:
Delphine Lebon, Marie-Noëlle Lacassagne, Berengere Gruson, Sandrine Castelain, Magalie Joris, Dujardin Adèle, Pierre Morel, Jean-Pierre Marolleau, Marine Quint, Amandine Charbonnier, Alexis Caulier
Publikováno v:
Blood
Blood, 2019, 134 (1), ⟨10.1182/blood-2019-123283⟩
Blood, 2019, 134 (1), ⟨10.1182/blood-2019-123283⟩
Introduction: Corticosteroid-refractory graft-versus-host disease (GVHD) remains a serious complication of hematopoietic stem cell transplantation (HSCT) with high morbidity and mortality rates. Unfortunately, no standard therapy exists for this sett
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f328e98e28bd33d6120b5aafb9990b2d
https://hal-u-picardie.archives-ouvertes.fr/hal-03592188
https://hal-u-picardie.archives-ouvertes.fr/hal-03592188
